Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$423M |
| 2 |
Mettler-Toledo International
MTD
|
+$421M |
| 3 |
Capital One
COF
|
+$383M |
| 4 |
L3Harris
LHX
|
+$325M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.83B |
| 2 |
Microsoft
MSFT
|
+$1.62B |
| 3 |
Apple
AAPL
|
+$1.56B |
| 4 |
NVIDIA
NVDA
|
+$1.36B |
| 5 |
Costco
COST
|
+$731M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.97% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 9.87% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Candel Therapeutics
CADL
$865M
| $439K | ﹤0.01% |
86,804
+26,045
| +43% | +$134K |
|
3527
Eagle Bancorp Montana
EBMT
$188M
| $438K | ﹤0.01% |
+26,299
| New | +$441K |
|
3528
Hain Celestial
HAIN
$52.9M
| $438K | ﹤0.01% |
287,983
-28,090
| -9% | -$65.6K |
|
3529
Verastem
VSTM
$629M
| $437K | ﹤0.01% |
105,404
+17,505
| +20% | +$110K |
|
|
SNBR
3530
DELISTED
Sleep Number
SNBR
| $436K | ﹤0.01% |
64,588
+1,330
| +2% | +$10.1K |
|
3531
Invesco Municipal Trust
VKQ
$545M
| $436K | ﹤0.01% |
47,650
+19,548
| +70% | +$181K |
|
3532
Avantis US Large Cap Value ETF
AVLV
$18.4B
| $435K | ﹤0.01% |
+6,377
| New | +$411K |
|
3533
Lands' End
LE
$391M
| $435K | ﹤0.01% |
40,590
-139
| -0.3% | -$1.26K |
|
|
MBX
3534
MBX Biosciences
MBX
$3.23B
| $434K | ﹤0.01% |
38,032
+14,122
| +59% | +$144K |
|
|
FRGE
3535
DELISTED
Forge Global Holdings
FRGE
| $433K | ﹤0.01% |
22,741
+3,273
| +17% | +$44.9K |
|
3536
Oak Valley Bancorp
OVLY
$283M
| $433K | ﹤0.01% |
15,886
-102
| -0.6% | -$2.6K |
|
|
CRGX
3537
DELISTED
CARGO Therapeutics
CRGX
| $431K | ﹤0.01% |
104,716
+9,187
| +10% | +$39.4K |
|
3538
Fennec Pharmaceuticals
FENC
$414M
| $430K | ﹤0.01% |
51,812
-1,694
| -3% | -$11.6K |
|
3539
EverCommerce
EVCM
$1.76B
| $429K | ﹤0.01% |
40,894
-11,725
| -22% | -$118K |
|
3540
Biote Corp
BTMD
$40.7M
| $428K | ﹤0.01% |
106,377
+14,835
| +16% | +$54.7K |
|
3541
Aldeyra Therapeutics
ALDX
$91.7M
| $426K | ﹤0.01% |
111,341
+410
| +0.4% | +$1.06K |
|
3542
Meridian
MRBK
$240M
| $426K | ﹤0.01% |
33,080
+16,252
| +97% | +$215K |
|
3543
Greene County Bancorp
GCBC
$601M
| $426K | ﹤0.01% |
19,190
+1,817
| +10% | +$40.3K |
|
3544
Sky Harbour Group
SKYH
$396M
| $425K | ﹤0.01% |
43,511
+19,794
| +83% | +$214K |
|
3545
C&F Financial
CFFI
$288M
| $424K | ﹤0.01% |
+6,874
| New | +$438K |
|
3546
ADC Therapeutics
ADCT
$156M
| $424K | ﹤0.01% |
158,135
-1,331
| -0.8% | -$2.8K |
|
3547
Allogene Therapeutics
ALLO
$714M
| $424K | ﹤0.01% |
375,037
+43,845
| +13% | +$58.3K |
|
3548
United States Antimony
UAMY
$799M
| $423K | ﹤0.01% |
+193,823
| New | +$549K |
|
3549
Concrete Pumping Holdings
BBCP
$479M
| $422K | ﹤0.01% |
68,544
-2,256
| -3% | -$14.3K |
|
|
ESPR
3550
DELISTED
Esperion Therapeutics
ESPR
| $420K | ﹤0.01% |
427,057
+11,916
| +3% | +$11.9K |
|
Similar funds
Bank of New York Mellon's Q2 2025 Portfolio in Review
As of Q2 2025, Bank of New York Mellon held 4,353 positions worth $529B, up 4.8% from $505B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon withdrew a net $22.6B in Q2 2025, closing 217 positions and reducing 1,932 holdings. Its most notable exit was Discover Financial Services, an estimated $274M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of New York Mellon opened a new position in JPMorgan Hedged Equity Laddered Overlay ETF worth $93.7M.
- Bank of New York Mellon's largest Q2 2025 buy was JPMorgan Hedged Equity Laddered Overlay ETF: 1,498,016 shares worth $93.7M.
- Bank of New York Mellon added most to Idexx Laboratories in Q2 2025, an estimated $423M increase.
- Bank of New York Mellon's biggest Q2 2025 reduction was Alphabet (Google) Class C, cutting an estimated $1.83B.
- Bank of New York Mellon fully exited Discover Financial Services in Q2 2025, selling an estimated $274M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $529B portfolio in Q2 2025.
- Bank of New York Mellon opened 243 new positions and closed 217 in Q2 2025.
- Bank of New York Mellon's portfolio value rose 4.8% quarter-over-quarter to $529B.
Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.